This guidance is intended to assist sponsors planning to conduct studies to assess theinfluence of renal impairment on the pharmacokinetics of an investigational drug. http://www.fdanews.com/ext/files/8551_Draft.pdf
This guidance is intended to assist sponsors planning to conduct studies to assess theinfluence of renal impairment on the pharmacokinetics of an investigational drug.
Online Survey Software powered by Cvent
Board Rules | advertise | Privacy
Copyright © 2004-2012 Scientist Solutions, All Rights Reserved.Resources from NCBI used on this site.